Skip to main content

Table 1 Cases and controls are matched by age, race, and history of hypertension

From: Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

   Total Controls Cases
  Number of patients 140 111 29
Age (years) Median (range) 56 (32–85)   
<50 yo 39 (28%) 30 (27%) 9 (31%)
>50 yo 101 (72%) 81 (73%) 20 (69%)
Gender Female 140 (100%)   
Race White 112 (80%) 93 (84%) 23 (79%)
Asian 18 (13%) 12 (11%) 2 (7%)
Black 10 (7%) 6 (5%) 4 (14%)
Baseline LVEF Median (range) 65% (50-77%)   
History of Hypertenson Yes 23 (16.4%) 18 (16%) 5 (17%)
No 117 (84%) 93 (84%) 24 (83%)